KAN-101 Phase 1 Clinical Trial Recruiting Now
The ACeD Study is looking for volunteers with celiac disease to participate in a phase 1 clinical trial testing the investigational drug KAN-101.
We lead the fight to increase the rate of diagnosis, to improve treatments, and to find a cure.Get the Latest Information and Resources on COVID-19 and Celiac Disease
Number of people worldwide affected by celiac disease
Diagnosed patients who still report symptoms while on gluten-free diet
Related family members who also have celiac disease
Increased risk of coronary artery disease/small bowel cancers